[Federal Register Volume 74, Number 111 (Thursday, June 11, 2009)]
[Notices]
[Page 27806]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-13678]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI-ARRA Competitive Revisions--Pre-Clinical, Drug Discovery 
& Imaging.
    Date: July 22-23, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel & Conference Center, 
Bethesda, MD.
    Contact Person: Michael B. Small, PhD, Scientific Review 
Officer, Division of Extramural Activities, National Cancer 
Institute, National Institutes Of Health, 6116 Executive Blvd., Room 
8127, Bethesda, MD 20892-8328, 301-402-0996, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control; 93.701, ARRA Related Biomedical Research and Research 
Support Awards, National Institutes of Health, HHS)

    Dated: June 4, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-13678 Filed 6-10-09; 8:45 am]
BILLING CODE 4140-01-P